Cost-utility analysis of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease in Thailand
PR
By Priya Raman · Science Reporter
Oct 24 16:15 ETSource: Baishideng Publishing Group
From the source
Read at wjgnet.comCost-utility analysis of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease in Thailand
